MY
Mymetics Corporation
MYMX · OTC
$0.00 +0.00% (+$0.00)
Market Cap 39.0 €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.01x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 69.99%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 47,966.70%
Net margin 160,167.00%
FCF margin 56,300.00%
Quality
0 /100
Poor ROIC 24.57%
ROA 65.63%
Asset turnover 0.00x
Debt
50 /100
Moderate Current ratio 0.01x
Int. coverage -0.72x
Net debt/EBITDA -36.02x
Stability
1 /100
Unstable Beta 2.36x
Rev. volatility 47.56%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre MYMX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ronald Kempers
Employees
2
Headquarters
Epalinges